Keratinocytes represent the first line of defense against pathogens in the skin and have important roles in initiating and regulating inflammation during infection and autoimmunity. Here we investigated the role of miR146a in the regulation of the innate immune response of keratinocytes. Toll-like receptor 2 (TLR2) stimulation of primary human keratinocytes resulted in an NF-kB-and mitogen-activated protein kinase-dependent upregulation of miR-146a expression, which was surprisingly long lasting, contrasting with the rapid and transient induction of inflammatory mediators. Overexpression of miR-146a significantly suppressed the production of IL-8, CCL20, and tumor necrosis factor-a, which functionally suppressed the chemotactic attraction of neutrophils by keratinocytes. Inhibition of endogenous miR-146a induced the production of inflammatory mediators even in nonstimulated keratinocytes, and potentiated the effect of TLR2 stimulation. Transcriptomic profiling revealed that miR-146a suppresses the expression of a large number of immune-related genes in keratinocytes. MiR-146a downregulated interleukin-1 receptor-associated kinase 1 and TNF receptor-associated factor 6, two key adapter molecules downstream of TLR signaling, and suppressed NF-kB promoter-binding activity as shown by promoter luciferase experiments. Together, these data identify miR-146a as a regulatory element in keratinocyte innate immunity, which prevents the production of inflammatory mediators under homeostatic conditions and serves as a potent negative feedback regulator after TLR2 stimulation.
INTRODUCTION
The skin provides a protective barrier that pathogens need to penetrate in order to invade the organism. Keratinocytes, the major cellular constituents of the epidermis, represent the first line of defense against pathogens in the skin and are an important part of the innate immune system. Upon external stimuli, such as physical trauma, bacterial and viral infections, or UV irradiation, keratinocytes produce numerous cytokines, chemokines, and antimicrobial peptides. These keratinocytederived inflammatory mediators serve as alarm signals for the innate and adaptive immune system, regulate the recruitment, activation, and retention of immune cells (neutrophils, granulocytes, dendritic cell precursors, and T cells) to the skin, and modulate their function (Goodarzi et al., 2007; Nestle et al., 2009 ). Recognition of pathogens by keratinocytes is a critical step in the cutaneous immune response. Pattern-recognition receptors, such as Toll-like receptors (TLRs), recognize conserved pathogen-associated molecular patterns (Kumar et al., 2011) . Human keratinocytes express several TLRs, including TLR2, which have important roles in the initiation of innate immune responses in the skin (Baker et al., 2003; Mempel et al., 2003; Pivarcsi et al., 2003; Kollisch et al., 2005; Lebre et al., 2007) . TLR2 recognizes a variety of lipopeptides from the cell wall of Gram-positive bacteria and yeast. Binding of specific ligands to TLR2 triggers an intracellular signaling cascade involving MyD88, IRAKs, and TNF receptor-associated factor 6 (TRAF6), leading to the activation of the NF-kB and mitogen-activated protein kinase (MAPK) pathways. This subsequently induces the expression of cytokines, chemokines, antimicrobial peptides, and adhesion molecules, which in turn can attract and activate immune cells to destroy invading microbes (Pivarcsi et al., 2004; Miller, 2008) .
MicroRNAs (miRNAs) are a class of evolutionarily conserved small noncoding RNAs that regulate gene expression on a post-transcriptional level (Ambros, 2004; Bartel, 2004) . Key roles for miRNAs have been found in nearly all biological processes and altered miRNA expression is associated with diseases (Farazi et al., 2013; Fernandez-Hernando et al., 2013) . MiRNAs are key regulators of inflammatory responses and immune regulation (Sonkoly et al., 2008; Ceribelli et al., 2012 ; O'Connell et al., 2012). MiR-146a was one of the first miRNAs identified to be involved in innate immune responses, being induced in macrophages upon stimulation with different TLR ligands and inflammatory cytokines (Taganov et al., 2006) .
Much is known about pathogen recognition and the initiation of innate immune response in keratinocytes (Begon et al., 2007; Buchau et al., 2008; Kalali et al., 2008; Lee et al., 2009; Dai et al., 2011; Niebuhr et al., 2011) . However, the mechanisms that prevent excessive/prolonged inflammation upon TLR activation in skin and the possible role of miRNAs in this process are not well understood. Thus, we set out to study the functional link between TLR2-induced miR-146a expression and the innate immune functions of keratinocytes. Our results identify miR-146a as a regulatory element in keratinocyte innate immunity, which serves as a negative feedback regulator after TLR2 stimulation and suppresses the production of inflammatory mediators under homeostatic conditions.
RESULTS

MiR-146a is induced upon engagement of TLR2 in keratinocytes
Initial studies were undertaken to characterize the expression of miR-146a in primary human keratinocytes upon TLR2 stimulation. Exposure to the TLR2 ligands zymosan and Pam 3 CSK 4 significantly induced miR-146a expression in keratinocytes after 24 hours (28-fold, Po0.001 and 8-fold, Po0.05, respectively; Figure 1a ). Silencing of TLR2 by specific small interfering RNA (siRNA; Supplementary Figure S1a online) abolished significantly the induction of miR-146a by zymosan (Po0.001) or Pam 3 CSK 4 (Po0.01; Figure 1b) , demonstrating that induction of miR-146a by both zymosan and Pam 3 CSK 4 was TLR2 dependent.
Next, we aimed to study the regulation of miR-146a upon zymosan treatment in more detail. Zymosan induced the expression of IL-8, CCL20, TNF-a, and miR-146a in a timeand concentration-dependent manner. Exposure to 100-300 mg ml À 1 zymosan resulted in significant expression of the inflammatory chemokines IL-8, CCL20, and TNF-a as well as of miR-146a (Supplementary Figure S2 online ). The induction of inflammatory mediators by zymosan was rapid and transient: the IL-8 and CCL20 response reached its peak after 3 hours, and that of TNF-a after 1 hour (Figure 1c ). MiR-146a was strongly upregulated by zymosan at 3 hours and the response peaked at 24 hours ( Figure 1c ). However, in contrast to the transient induction of inflammatory mediators, miR146a expression did not return to baseline level but remained significantly elevated at all time points studied, up to 96 hours. The observed kinetics of miR-146a expression upon TLR2 stimulation suggested that miR-146a may be involved in the resolution of the inflammatory response. To understand whether the high expression of miR-146a at later time points depends on transcriptional events or is due to the stability of miR-146a, we measured the expression of the primary transcript, pri-miR-146a. Interestingly, zymosan induced primiR-146a only transiently at very high levels (43-fold, Po0.001 at 3 hours), but not at later time points, in contrast to the mature miR-146a (Figure 1c ). These results suggest that the prolonged high level of miR-146a upon zymosan stimulation is mainly due to the stability of the mature miRNA.
Induction of miR-146a upon TLR2 stimulation is mediated through the NF-jB and MAPK pathways
To explore the intracellular pathways that lead to the induction of miR-146a upon TLR2 stimulation, we used specific chemical inhibitors that target pathways known to act downstream of TLR2 signaling, i.e., the NF-kB and MAPK pathways. We used inhibitors for NF-kB (BAY-11-7082), JNK (SP600125), MEK1/2 (U0126), p38 (SB203580), and we included an inhibitor for PI3K (Wortmannin). None of these inhibitors had an effect on the miR-146a baseline expression (Figure 1d ), suggesting that these pathways are not involved in the baseline transcription of the miR-146a gene. Induction of miR-146a by zymosan was reduced sevenfold (Po0.001) by pretreatment with the NF-kB inhibitor BAY-11-7082 (Figure 1d ). The MEK1/2 inhibitor U0126 and the p38 inhibitor SB203580 also reduced zymosan-induced miR-146a expression to a lesser extent (2.2-fold, Po0.01 and 2.3-fold, Po0.01, respectively), suggesting that these MAPK pathways contribute to the induction of miR-146a. In contrast, the JNK inhibitor SP600125 and the PI3K inhibitor Wortmannin had no effect on zymosan-induced miR-146a expression. These results demonstrate that zymosan-induced miR-146a expression in keratinocytes is mediated via the NFkB pathway and to a lesser extent by the MEK1/2 and p38 MAPK pathways.
MiR-146a suppresses the zymosan-induced production of inflammatory mediators in keratinocytes
To assess the functional relevance of miR-146a expression under inflammatory conditions, we studied the effect of miR146a on TLR2-induced expression of selected inflammatory mediators. To that end, we transfected primary human keratinocytes with synthetic miR-146a or scrambled control oligonucleotides (Supplementary Figure S1b online ). Keratinocytes were stimulated with zymosan 48 hours after transfection and the expression and secretion of the inflammatory mediators IL-8, CCL20, and TNF-a were determined 6 and 24 hours later via quantitative real-time reverse-transcriptase-PCR and ELISA (Figure 2a ; results from unstimulated control cells are shown in Figure 3 ). Overexpression of miR-146a markedly suppressed TLR2-induced expression and production of IL-8, CCL20, and TNF-a. To determine whether the TLR2-induced endogenous miR-146a can act as a negative feedback in keratinocytes, we inhibited miR-146a expression using specific inhibitors or scrambled controls before zymosan treatment (Figure 2b ). Inhibition of endogenous miR-146a further increased TLR2-induced expression and production of IL-8, CCL20, and TNF-a, demonstrating that zymosan-induced miR146a expression acts as a negative feedback on this pathway.
MiR-146a suppresses the production of inflammatory mediators in resting keratinocytes
To further explore the function of miR-146a in keratinocytes, the expression of selected inflammatory mediators was also measured in unstimulated keratinocytes upon modulation of miR-146a expression. The messenger RNA expression and protein secretion of IL-8, CCL20, and TNF-a were low in resting keratinocytes; however, overexpression of miR-146a decreased their levels even further (Figure 3a , Supplementary Figure S3 online), with the exception of TNF-a, which could not be detected in supernatants of unstimulated keratinocytes. Next, we aimed at exploring the function of homeostatic miR146a expression in resting keratinocytes. Surprisingly, inhibition of the relatively low-expressed endogenous miR-146a in unstimulated keratinocytes markedly increased expression and release of IL-8, CCL20, and TNF-a (Figure 3b , Supplementary  Figure S3 online). These results imply that endogenous miR-146a has a role in the suppression of inflammatory mediators in keratinocytes in the absence of pathogens.
Overexpression of miR-146a induces profound changes in the transcriptome of keratinocytes Next, we aimed to explore the effect of miR-146a on the transcriptome of keratinocytes. Global transcriptome analysis using Affymetrix array identified 433 genes whose levels were significantly regulated by overexpression of miR-146a in keratinocytes (Supplementary Table S1 online). In addition to IL-8, CCL20 and TNF-a, many other chemokines, cytokines, antimicrobial peptides, and growth factors were regulated by miR-146a. To gain insights into the role of miR-146a in keratinocytes, we searched for over-representation of functional categories among miR-146a-regulated genes. Functional annotation of miR-146a-regulated genes revealed that genes involved in biological processes such as ''immune response'', ''inflammation'', ''host defense'', or ''chemotaxis'' were highly enriched among miR-146a-regulated genes, suggesting that miR-146a preferentially regulates these biological and molecular processes (Figure 4a ). Classification according to molecular function showed that genes classified as cytokines, chemokines, or membrane channel proteins were significantly enriched ( Figure 4b ). Interestingly, classification of the regulated genes according to their location in subcellular structures revealed that secreted proteins and membrane proteins were highly enriched (Figure 4c ), suggesting that miR-146a preferentially regulates genes involved in cell-cell communication. These findings demonstrate that miR-146a has a profound effect on the transcriptome and regulates a large number of genes involved in the immune function of keratinocytes: among them are cytokines (e.g., IL1b, IL-6, IL-17F, IL-23A, TNF-a), chemokines (e.g., CCL5, CCL20, CXCL1, CXCL2, CXCL10, CXCL11, IL-8), antimicrobial peptides (e.g., DEFA5, DEFB4A, DEFB113), and HLA genes (e.g., HLA-DPA1, -DQA1, -DQA2) (Figure 4d ). 
Figure 2. MiR-146a suppresses the TLR2-induced production of IL-8, CCL20, and TNF-a in keratinocytes. Keratinocytes were transfected with (a) miR-146a precursor (pre-miR-146a) or scrambled control precursor (pre-miR-Ctrl); (b) miR-146a inhibitor (anti-miR-146a) or scrambled control inhibitor (anti-miR-Ctrl). After 48 hours, cells were exposed to 100 mg ml À 1 zymosan. The expression and secretion of IL-8, CCL20, and TNF-a were determined 6 and 24 hours later using qRT-PCR and ELISA, respectively. qRT-PCR, quantitative real-time reverse-transcriptase-PCR; TLR, Toll-like receptor; TNF, tumor necrosis factor; *Po0.05; **Po0.01; ***Po0.001.
MiR-146a suppresses NF-jB-dependent promoter-binding activity in keratinocytes
The induction of an inflammatory response upon TLR stimulation in keratinocytes is mainly mediated via the NF-kB signaling pathway (Kollisch et al., 2005) . Therefore, we tested whether miR-146a influences the expression of NFkB-related genes. Gene set enrichment analysis of the transcriptome-wide profiling revealed significant enrichment of NF-kB target genes among genes suppressed by miR-146a (Figure 4e ), suggesting that this pathway is preferentially targeted by miR-146a in keratinocytes. Next, we aimed to determine whether miR-146a has a direct effect on NF-kB activation. To that end, we transfected keratinocytes with an NF-kB luciferase reporter. Measurement of luciferase activity upon zymosan stimulation revealed a 13-fold increase in the NF-kB-dependent DNA-binding activity, in accordance with previous reports (Olaru and Jensen, 2010) . Overexpression of miR-146a significantly suppressed zymosan-induced NF-kB activity (0.57-fold, Po0.05), indicating that miR-146a can suppress the NF-kB signal transduction pathway in keratinocytes. This contention was supported by the effect of miR-146a inhibitors, which resulted in further elevated zymosan-induced NF-kB activity (1.79-fold, Po0.01) (Figure 4f ). Altogether, these data imply that zymosan-induced miR-146a expression is an effective suppressor of NF-kB activity in keratinocytes.
MiR-146a represses the attraction of neutrophils
To investigate the functional implication of this massive change of gene expression in keratinocytes upon miR-146a modulation, we tested the chemotactic potential of keratinocytes to attract neutrophil granulocytes. To that end, we let , and TNF-a in unstimulated keratinocytes. Keratinocytes were transfected with (a) miR-146a precursor (pre-miR-146a) or scrambled control precursor (pre-miR-Ctrl); (b) miR-146a inhibitor (anti-miR-146a) or scrambled control inhibitor (anti-miR-Ctrl). Fiftyfour or 72 hours after transfection, the expression and secretion of IL-8, CCL20, and TNF-a were determined using qRT-PCR and ELISA, respectively. ND, not detected; qRT-PCR, quantitative real-time reverse-transcriptase-PCR; TNF, tumor necrosis factor; *Po0.05; **Po0.01; ***Po0.001.
primary neutrophils migrate toward the supernatant of keratinocytes that overexpressed or were inhibited for miR-146a in a Boyden chamber. Counting of the migrated neutrophils showed that miR-146a overexpression in keratinocytes significantly reduced chemotactic migration (0.54-fold, Po0.05), whereas miR-146a inhibition led to a strong increase in neutrophil attraction (5.87-fold, Po0.05; Figure 4g) . These results clearly demonstrate the functional relevance of miR146a expression in keratinocytes.
MiR-146a suppresses IRAK1 and TRAF6 expression in keratinocytes
Interleukin-1 receptor-associated kinase 1 (IRAK1) and TRAF6 have been identified as direct targets of miR-146a in macrophages (Taganov et al., 2006) ; however, they are not targeted by miR-146a in lung epithelial cells (Perry et al., 2008) . As IRAK1 and TRAF6 are important parts of the signaling cascade between TLRs and the NF-kB pathway (Takeda and Akira, 2004) , we hypothesized that the observed effect of miR-146a could be mediated by repression of IRAK1 and TRAF6 in keratinocytes. We found that overexpression of miR-146a significantly suppressed IRAK1 and TRAF6 expression in keratinocytes, both at the messenger RNA and the protein level, whereas miR-146a inhibition led to an increased expression of IRAK1 and TRAF6 (Figure 5a and b) . These results suggest that miR-146a can reduce the activity of the TLR/NF-kB pathway in keratinocytes by downregulating IRAK1 and TRAF6. To confirm the importance of IRAK1 in the miR-146a-mediated regulation of TLR signaling, we knocked down IRAK1 using siRNA (Supplementary Figure   APLN  CCL20  CCL5  CCR5  CD1E  CD38  CFD  CHIA  CHRNA10  CHRNA8  CNTFR  COLEC12  CSF2  CSF3  CTSS  CXCL1  CXCL10  CXCL11  CXCL2  DEFA5  DEFB113  DEFB4A  EBF3  FGF3  FYB  GBP5  GDF5  GEM  GLRB  GRIN2C  GRM5  HLA-DPA1  HLA-DQA1  HLA-DQA2  ICAM1  IGKC  IL17F  IL1B  IL1R2  IL23A  IL2RG  IL6  IL8  IRAK1  ITIH4  KYNU  LAT  LY9  NF5A1  OPRK1  PLA2G2E  PYY  RAPSN  SAA1  SERPINA3  SIGLEC1  STAT5  TNF  TRAF6  TRH   #1  #1  #2 #3  #3 Pre-miR-146a
Anti-miR-Ctrl Anti-miR-146a Figure 4 . MiR-146a suppresses the expression of inflammatory mediators in keratinocytes by inhibition of NF-jB activation and represses neutrophil chemotaxis. Global transcriptome profiling was performed in independent biological triplicates for primary human keratinocytes transfected with either miR-146a precursor (pre-miR-146a) or scrambled control precursor (pre-miR-Ctrl). (a-c) Significantly regulated genes were categorized according to their biological or molecular function or their cellular location, using GO terms. The most highly enriched categories are shown. (d) Selected deregulated genes involved in inflammation are displayed as a heat map, green indicating low expression, red indicating high expression. Cytokines are labeled in magenta, chemokines in green, defensins in blue, and HLA genes in purple. (e) Genes represented in the profile data set were ranked by fold change (pre-miR-146a/pre-miR-Ctrl). GSEA evaluated enrichment within the profile data set for the reported target genes of the NF-kB signaling pathway. Vertical bars along the x-axis of the GSEA plot denote the positions of the NF-kB target genes within the ranked list. (f) Keratinocytes were co-transfected with an NF-kB luciferase reporter plasmid and miR-146a precursor/inhibitor or regarding controls for 48 hours, exposed to medium or 100 mg ml À 1 zymosan, and luciferase activity was measured after 6 hours.
(g) Keratinocytes were transfected with miR-146a precursor/inhibitor or regarding controls for 48 hours. The keratinocyte supernatant was used to attract primary neutrophils in a Boyden chamber and counted using flow cytometry. Plots showing forward/side scatter and quantification of migrated neutrophils. GO, Gene Ontology; GSEA, gene set enrichment analysis; NES, normalized enrichment score; *Po0.05; **Po0.01. S1c-d online) in the presence or absence of miR-146a inhibitors. Although baseline expression of IL-8 was unaffected by IRAK1 knockdown, zymosan-induced IL-8 expression was abolished in keratinocytes in which both miR-146a and IRAK1 were depleted, confirming the importance of IRAK1 as a mediator of the effect of miR-146a during inflammatory responses in primary human keratinocytes (Figure 5c ).
DISCUSSION
Skin is frequently in contact with a variety of microorganisms, and keratinocytes are the first line of defense within skin that sense the ''danger'' signals, among others, via TLRs. Impaired balance between the appropriate inflammatory response and the timely shutdown may lead to the development of inflammatory skin diseases (Lai and Gallo, 2008) . In this study, we identify miR-146a as a potent negative regulator of the innate immune response in keratinocytes.
The rapid and high induction of miR-146a in keratinocytes upon encounter with TLR2 ligands is analogous to miR-146a induction by TLR ligands in immune cells (Jurkin et al., 2010; Boldin et al., 2011; El Gazzar et al., 2011; Quinn et al., 2013) as well as in some nonimmune cell types such as microglial cells (Saba et al., 2012) and intestinal epithelial cells (Chassin et al., 2012) , supporting a role for miR-146a as a general *** *** Figure 5 . MiR-146a downregulates IRAK1 and TRAF6 in keratinocytes. Keratinocytes were transfected with miR-146a precursor (pre-miR-146a), scrambled control precursor (pre-miR-Ctrl), miR-146a inhibitor (anti-miR-146a), or scrambled control inhibitor (anti-miR-Ctrl) for 72 hours, and the expression of IRAK1 mRNA and protein was determined by (a) qRT-PCR and (b) western blotting, respectively. Densitometry quantification is normalized to actin. (c) Keratinocytes were co-transfected with miR-146a inhibitor (anti-miR-146a) or scrambled control inhibitor (anti-miR-Ctrl) and with IRAK1-specific siRNA (siRNA IRAK1) or scrambled control siRNA (siRNA Ctrl) for 48 hours, and were subsequently treated with zymosan for 3 hours. *Po0.05; ***Po0.001. (d) Schematic summary of the regulation and function of miR-146a in keratinocytes. IRAK1, interleukin-1 receptor-associated kinase 1; mRNA, messenger RNA; qRT-PCR, quantitative real-time reverse-transcriptase-PCR; siRNA, small interfering RNA; TRAF6, TNF receptor associated factor 6.
regulator of the innate immune response. We show that, in addition to NF-kB, MEK1/2 and p38 are also involved in the TLR2-dependent induction of miR-146a in keratinocytes, suggesting a more complex and fine-tuned regulation of miR-146a besides the acute inflammatory NF-kB pathway. This is in agreement with the fact that TLR2 signaling primarily proceeds through the NF-kB pathway, and in addition through three different MAPK pathways (JNK, Erk1/2, and p38; Deva et al., 2003; Into et al., 2004) . MiR-146a expression has been shown to be regulated through the activation of the NF-kB pathway in other cell types (Taganov et al., 2006; Bhaumik et al., 2008; Perry et al., 2009; Curtale et al., 2010) . Interestingly, in alveolar epithelial cells miR-146a is induced via NF-kB and JNK, but not via MEK1/2 or p38 (Perry et al., 2009) , indicating that the regulation of miR-146a expression may partly be cell-type dependent.
In agreement with earlier reports (Kawai et al., 2002; Pivarcsi et al., 2003; Kollisch et al., 2005) , inflammatory mediators and host defense genes (IL-8, CCL20, and TNF-a) were transiently induced upon TLR2 engagement in keratinocytes as a part of keratinocyte host defense response. In contrast, miR-146a remained elevated for at least 4 days following TLR2 stimulation in keratinocytes. This prolonged high level of miR-146a in keratinocytes upon zymosan treatment may be mainly due to the stability of mature miR-146a rather than sustained transcriptional upregulation, as we found that the primary transcript of miR-146a was not significantly upregulated after 24 hours. Although the precise mechanisms of miRNA decay are yet unknown, the half-life of miRNAs in cells can be several days long (Bail et al., 2010; Gantier et al., 2011) .
MiR-146a strongly suppressed the zymosan-induced expression of IL-8, CCL20, and TNF-a in keratinocytes. Importantly, not only ectopic overexpression of miR-146a but also zymosan-induced endogenous miR-146a at physiological concentrations can efficiently suppress these mediators, as evidenced by the marked enhancement of zymosan-induced release of inflammatory mediators upon inhibition of miR-146a. These findings demonstrate that miR-146a regulates the acute inflammatory response of keratinocytes upon TLR2 engagement. Strikingly, miR-146a had a profound effect on a vast variety of inflammatory genes: among them are the three major neutrophil-attracting chemokines, IL-8, CXCL1, and CXCL2. In accordance with this, we demonstrated a negative effect of miR-146a on the neutrophil-attracting capacity of keratinocytes. The relative contribution of IL-8, CXCL1, CXCL2, and maybe other chemokines on this effect remains to be investigated.
Interestingly, inhibition of endogenous miR-146a led to markedly enhanced expression and secretion of inflammatory mediators even in the absence of stimulation, indicating that physiological concentrations of miR-146a in resting keratinocytes have a profound effect on the production of inflammatory mediators. This implies that loss/downregulation of miR-146a may lead to autoinflammatory/autoimmune conditions. Indeed, targeted deletion of miR-146a leads to an autoimmune phenotype and exaggerated inflammatory response in mice (Boldin et al., 2011; Yang et al., 2012) . Surprisingly, even mice overexpressing miR-146a develop spontaneous signs of autoimmunity (Guo et al., 2013) , highlighting the complex role of miR-146a in the regulation of inflammation and autoimmunity in vivo. In psoriasis, a chronic inflammatory skin disease, a strong immune response in the skin is provoked, although no danger signals are present. Interestingly, miR-146a is overexpressed in psoriasis skin, suggesting that it cannot fully compensate for the deregulated immune response of keratinocytes (Sonkoly et al., 2007) . Thus, deregulation of miR-146a expression may have a role in inflammatory skin diseases. Recently, it has been shown that TLR2 signaling can suppress the TLR3 pathway (Lai et al., 2009) ; thus, overexpression of miR-146a may contribute to skin inflammation by enhancing TLR3 signaling. Further studies are needed to appreciate the role of miR-146a in psoriasis and other inflammatory skin diseases.
Our data demonstrate that miR-146a suppresses the NF-kB promoter-binding activity in keratinocytes. Accordingly, overexpression of miR-146a led to the downregulation of a large number of mediators of key importance of the innate immune function in keratinocytes, such as chemokines, cytokines, antimicrobial peptides, and signaling molecules and receptors. In addition to IL-8, other chemokines such as CCL5, CXCL10, and CXCL11 were downregulated, suggesting that miR-146a may regulate the recruitment of several immune cell types to the skin upon injuries or infections. Moreover, we show that miR-146a downregulates IRAK1 and TRAF6 in keratinocytes, two previously identified bona fide targets of miR-146a. Our results thus suggest a model in which miR-146a suppresses NF-kB activity and inflammation through the targeting of IRAK1 and TRAF6 (Figure 5d ).
In conclusion, we have identified a previously unrecognized regulatory mechanism in keratinocyte innate immunity, in which TLR2-ligand-induced miR-146a acts as a negative feedback regulator of inflammation through downregulation of the IRAK1/TRAF6/NF-kB pathway. Thus, miR-146a may contribute to the resolution of inflammation by shutting down excess inflammatory responses in keratinocytes exposed to microbial agents, whereas under homeostatic conditions it may function by setting the threshold of the response to external stimuli, thus preventing autoimmunity in the absence of pathogens.
MATERIALS AND METHODS
Cell culture
Normal human adult epidermal keratinocytes were purchased from Life Technologies (Carlsbad, CA) and cultured in EpiLife serum-free medium including human keratinocyte growth supplement and 100 U ml À 1 penicillin/streptomycin at 37 1C in 5% CO 2 . Human keratinocyte growth supplement was removed 1 day before treatment or transfection in order to avoid disturbance by the presence of hydrocortisone. Keratinocytes were treated with zymosan (100 mg ml ) (Invivogen, Toulouse, France). For inhibiting signaling pathways, keratinocytes were treated with BAY-11-7082, SB203580, U0126 (Merck, Darmstadt, Germany), or SP600125 (Santa Cruz Biotechnology, Santa Cruz, CA) at 10 mM or Wortmannin (Merck) at 1 mM concentration. After 1 hour, medium or zymosan was added and cells were collected 24 hours later. To study the biological effects of miR-146a on keratinocytes, third passage keratinocytes at 50-60% confluence were transfected using Lipofectamine 2000 (Life Technologies) with 1 nM pre-miR miR-146a precursor or negative control #1 (Life Technologies); 50 nM miRCURY LNA miRNA Power inhibitor for hsa-miR-146a or negative control A (Exiqon, Vedbaek, Denmark); 10 nM Silencer select siRNA for TLR2 or siRNA negative control #1; 160 nM siRNA for IRAK1 or siRNA negative control (Life Technologies). Efficiency of the transfections was determined by quantitative real-time reverse-transcriptase -PCR (Supplementary Figure S1 online) .
RNA extraction and quantitative real-time PCR
Total RNA was extracted using Trizol (Life Technologies) or the miRNeasy Mini kit (Qiagen, Hilden, Germany). Quantification of miR-146a was performed using TaqMan Real-Time PCR (Life Technologies) according to the manufacturer's protocols and normalized toward U48 RNA using DCt calculation. To quantify messenger RNAs, total RNA was reverse transcribed using the RevertAid First Strand cDNA Synthesis Kit (Fermentas, Pittsburgh, PA). TLR2, CCL20, IRAK1, TRAF6, and pri-miR-146a were quantified by TaqMan gene expression assays (Life Technologies); IL-8 and TNF-a were quantified using specific primers and probes (IL-8 fwd: (Subramanian et al., 2005) analyses were performed as previously described.
Neutrophil chemotaxis assay
Primary human neutrophils were isolated from 0.2% EDTA-anticoagulated whole blood collected by venipuncture from healthy donors. Erythrocytes were removed using dextran sedimentation (2:1 mixture of blood:6% dextran/0.9% NaCl), followed by hypotonic lysis using double-distilled H 2 O. Purified leukocytes were suspended in EpiLife serum-free keratinocyte growth medium, and 6 Â 10 5 cells were added to the inner chamber of a 3-mm polyethylene terephthalate membrane cell culture insert (BD Falcon, Erembodegem, Belgium). The outer chamber contained culture medium from keratinocytes transfected with pre-miR-146a, pre-miR-Ctrl, anti-miR146a, or anti-miR-Ctrl. After incubation for 1.5 hours at 37 1C in 5% CO 2 , the migrated neutrophils in the outer chamber were quantified by flow cytometry, normalizing the culture medium volume by addition of CountBright counting beads (Life Technologies). Protein detection and luciferase assays are described in Supplementary Information online.
